Article in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Maria N VikhrevaPenza Institute for Advanced Medical Education-Branch of the Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, 8A Stasov Str., Penza 440060, Russia.ORCID 0009-0002-7977-5441
Lavrenty G DanilovFederal State Budgetary Educational Institution of Higher Education "St. Petersburg State University", 7-9 Universitetskaya Nab., Saint Petersburg 199034, Russia.ORCID 0000-0002-4479-3095
Andrey A MartynovFederal State Budgetary Research Institution "Russian Research Center of Surgery Named After Academician B.V. Petrovsky", Abrikosovsky Lane, 2, Moscow 119991, Russia.
Olga A LevashovaPenza Institute for Advanced Medical Education-Branch of the Federal State Budgetary Educational Institution of Further Professional Education "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, 8A Stasov Str., Penza 440060, Russia.ORCID 0000-0002-8440-6598
Svetlana N TuchkovaFederal State Budgetary Research Institution "Russian Research Center of Surgery Named After Academician B.V. Petrovsky", Abrikosovsky Lane, 2, Moscow 119991, Russia.ORCID 0009-0001-2744-2752
Sherzod P AbdullaevFederal State Budgetary Research Institution "Russian Research Center of Surgery Named After Academician B.V. Petrovsky", Abrikosovsky Lane, 2, Moscow 119991, Russia.ORCID 0000-0001-9001-1499
Karin B MirzaevFederal State Budgetary Research Institution "Russian Research Center of Surgery Named After Academician B.V. Petrovsky", Abrikosovsky Lane, 2, Moscow 119991, Russia.ORCID 0000-0002-9307-4994
Andrey S GlotovFederal Scientific and Clinical Center for Infectious Diseases of the Federal Medical Biological Agency of Russian Federation, 9A Professora Popova Str., Saint Petersburg 197022, Russia.ORCID 0000-0002-7465-4504
Oleg S GlotovFederal Scientific and Clinical Center for Infectious Diseases of the Federal Medical Biological Agency of Russian Federation, 9A Professora Popova Str., Saint Petersburg 197022, Russia.ORCID 0000-0002-0091-2224
Dmitry A SychevFederal State Budgetary Research Institution "Russian Research Center of Surgery Named After Academician B.V. Petrovsky", Abrikosovsky Lane, 2, Moscow 119991, Russia.ORCID 0000-0002-4496-3680
Funding
Federal Scientific-technical program for genetic technologies development for 2019-2030 075-15-2025-463
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
drug responsemethotrexatepersonalized medicinepharmacogenetic markerspsoriasis
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Genetic Markers of Methotrexate Treatment Failure in Psoriasis. · full record | OpenQuestion